Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 181.69

-2.2%

10:13 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (7660)	9/26/1997 12:53:00 PM
From: MWP	of 32384

>>I assume that ALRT326 and ALRT4204 would have applications for diabetes<< Henry, BioWorld Today has a summary of the LGND/AGN deal and do say that ALRT326 and ALRT4202 are being developed for possible use against Type II diabetes. They also quote Molowa (Bear Sterns) as saying that AGN doesn't want to become a cancer co., just be in the revenue stream. MWP

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next